Convexity Labs

BLFY

Convexity Analyst · BLFY
Speculativemedium confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: BLFY (Blue Foundry Bancorp) Date: 2026-06-13 Current Price: $12.43

1. Structural Readiness

Conservative Entry: Not yet defined (awaiting breakout confirmation) Aggressive/Pre-Breakout Entry: N/A (Current price is not at a defined entry trigger; price is holding above support but has not initiated the breakout leg) Breakout Level: Not yet defined Current Price: $12.43 Extension: Not applicable (Price has not broken out of the coil structure) ATR Current: 3.4% (Productive)

Analysis of Setup:

2. Thesis Layer

Thesis Classification: TACTICAL / Setup-Led Secular Thesis: None named at this date.

This is a tactical, setup-led name. There is no named macro or secular thesis driving the conviction at this specific moment. The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the underlying business fundamentals as reported by management. No external macro narrative should be invented to support the position.

3. Business Overview

Company: Blue Foundry Bancorp (BLFY) Industry: Financial Services / Banking Business Model: BLFY functions as the parent company for Blue Foundry Bank, a savings institution operating 17 full-service branch locations in northern New Jersey. The company provides a full suite of banking solutions, including deposit accounts and a diverse array of lending options.

Key Business Metrics & Management Expectations (as of Q3 2025 Earnings, Oct 29, 2025):

  • Loan Pipeline & Origination: Management reports a healthy loan pipeline with over $41 million in executed letters of intent, primarily in commercial lending. The anticipated weighted average rate on this pipeline is approximately 7%.
  • *Source:* [E1], [E8]
  • Repricing Dynamics: Management expects downward rate movements to benefit funding costs. They anticipate repricing in the loan portfolio to have a favorable impact on Net Interest Margin (NIM).
  • $45 million of loans are coming in at sub-4% rates (maturity/repricing).
  • $35–$40 million is expected in the latter half at sub-3.75% rates.
  • *Source:* [E2], [E3]
  • Portfolio Growth:
  • Commercial: Grew by $7.2 million in the quarter, driven by strong origination activity of $81.3 million (including ~$40 million in owner-occupied CRE and C&I), offset by $66.8 million in payoffs.
  • Consumer: Increased by $38 million in Q3, supported by purchases of unsecured consumer loans with credit reserves.
  • *Source:* [E5], [E6]
  • Deposit Growth: Year-to-date, core deposits grew by over 10%, and commercial deposits grew by over 17%. Total deposits increased by $77.1 million in the reported quarter.
  • *Source:* [E4], [E7]
  • Product Mix: Services include mortgages (1-4 family), home equity loans/lines, commercial real estate financing, multi-family loans, construction loans, C&I loans, and consumer credit.
  • *Source:* [E10], [E11]

4. Archetype and Conviction Stack

Archetype: Deep Value Recovery Rationale: The name fits the "Deep Value Recovery" archetype based on the combination of a low price point ($12.43), a micro-cap classification, and management's focus on margin expansion through favorable repricing and deposit growth. The business is showing signs of operational recovery with double-digit deposit growth and a robust loan pipeline at attractive rates.

Valuation & Financial Spine:

  • Forward Consensus EPS: FY1 is projected at -0.15, and FY2 at 0.18.
  • *Source:* [E13]
  • Context: The negative FY1 consensus suggests the market is pricing in a near-term earnings dip or normalization, while FY2 projects a return to profitability. This aligns with a "recovery" narrative where the current price reflects the trough of earnings before the FY2 inflection.

Conviction Stack:

  • Thesis Strength: Low (No named macro thesis; purely tactical).
  • Evidence Quality: High (Strong, specific management guidance on pipeline, rates, and deposit growth from Q3 2025).
  • Structural Quality: Moderate (ATR of 3.4% is in the "productive" range, indicating healthy volatility without being extreme. The forming coil structure is in place but unconfirmed).
  • Setup Readiness: Partial (Forming coil; requires breakout confirmation).
  • Rerating Potential: Moderate (Dependent on the realization of the FY2 earnings recovery and the successful execution of the loan pipeline).

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

  • Breakout Confirmation: A daily close above the coil resistance level (once defined) would confirm the "Confirmed-Active" state.
  • Margin Expansion: Continued expansion of Net Interest Margin (NIM) as management expects, driven by the favorable repricing of the loan portfolio.
  • Deposit Retention: Sustained growth in core and commercial deposits beyond the 10-17% YTD figures reported in Q3 2025.

What Would Invalidate the Case:

  • Pipeline Erosion: A significant reduction in the $41 million letter of intent pipeline or a failure to maintain the ~7% weighted average rate on new originations.
  • Credit Quality Deterioration: An unexpected spike in charge-offs or reserve requirements, particularly in the commercial or consumer portfolios.

Gaps in Evidence Base:

  • Breakout Trigger: The specific price level required to trigger the breakout is not yet defined.
  • Macro Context: No specific macro thesis is provided to contextualize the "Deep Value" claim beyond the company's internal metrics.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Loan pipeline of $41M at ~7% rates; Commercial deposits up 17% YTD; Forming coil structure with price holding above support; ATR of 3.4% indicating productive volatility. Key risks: FY1 consensus EPS of -0.15 indicates near-term earnings pressure; Breakout not yet fired (setup incomplete); No named macro thesis to support conviction; Potential for credit deterioration in commercial/consumer portfolios. Sizing hint: Position size should be conservative given the "forming" status and lack of confirmed breakout; treat as a partial position pending confirmation. Expected path: Management expects NIM expansion via favorable repricing and funding cost reductions; loan pipeline execution should drive revenue growth into FY2. Expected horizon: 3 to 6 months for the forming coil to resolve into a confirmed breakout or invalidation.

Loading chart...
Exhibit 1: BLFY daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for BLFY.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for BLFY.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: